Stericycle (NASDAQ: SRCL) reported Q4 EPS of $0.59, $0.04 worse than the analyst estimate of $0.63. Revenue for the quarter came in at $655.9 million versus the consensus estimate of $651.1 million.

“Stericycle delivered a strong fourth quarter performance and continued to build on the momentum of our key business priorities in uncertain times,” said Cindy J. Miller, Chief Executive Officer. “We benefited from expanding margins through our quality of revenue initiatives, operating efficiency initiatives and portfolio rationalization, along with significant operating cash flow generation and disciplined capital expenditure deployment. Also, we achieved an effective internal control environment as of December 31, 2020, having successfully remediated material weaknesses.”

For earnings history and earnings-related data on Stericycle (SRCL) click here.